Cargando…

The Incidence of Hypothyroidism Following the Radioactive Iodine Treatment of Graves’ Disease and the Predictive Factors Influencing its Development

The purpose of this study is to evaluate and compare the incidence of hypothyroidism following different fixed radioactive iodine-131 ((131)I) activities in the treatment of Graves’ disease (GD) and to investigate the predictive factors that may influence its occurrence. This retrospective analysis...

Descripción completa

Detalles Bibliográficos
Autor principal:	Husseni, Maha Abd El-Kareem El-Sayed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729012/ https://www.ncbi.nlm.nih.gov/pubmed/26912976 http://dx.doi.org/10.4103/1450-1147.167582

Ejemplares similares

Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves’ disease patients
por: Hu, Rui-Ting, et al.
Publicado: (2020)

Acute psychosis caused by hypothyroidism following radioactive iodine treatment of Graves' disease
por: Hyams, Catherine, et al.
Publicado: (2013)

No impact of dietary iodine restriction in short term development of hypothyroidism following fixed dose radioactive iodine therapy for Graves’ disease
por: Jacob, Jubbin Jagan, et al.
Publicado: (2015)

TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for hypothyroidism in Graves’ disease
por: Verdickt, Sébastien, et al.
Publicado: (2022)

Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
por: Kim, Sun Hwa, et al.
Publicado: (2013)

Prediction of post-treatment hypothyroidism using changes in thyroid volume after radioactive iodine therapy in adolescent patients with Graves' disease
por: Nakatake, Nobuhiro, et al.
Publicado: (2011)

Thyroid storm following radioactive iodine (RAI) therapy for pediatric graves disease
por: Rohrs, Henry J., et al.
Publicado: (2014)

Change in BMI after radioactive iodine ablation for graves disease
por: Chen, Melinda, et al.
Publicado: (2017)

Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease
por: Kim, Min Joo, et al.
Publicado: (2022)

The assessment of radio-adaptive response in graves' hyperthyroidism patients following radioactive iodine uptake
por: Fazeli, Zahra, et al.
Publicado: (2018)

Predictive factors for the outcomes of Graves’ disease patients with radioactive iodine ((131)I) treatment
por: Xing, Yu-Zhuo, et al.
Publicado: (2020)

Profile of Levothyroxine Replacement Therapy in Graves’ Disease Patients with Hypothyroidism Post-Radioactive Iodine Ablation: Focus on Different Weight-Based Regimens
por: Mathiphanit, Saravut, et al.
Publicado: (2022)

Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease
por: Cury, Adriano N, et al.
Publicado: (2012)

Chylothorax Associated with Substernal Goiter in Graves’ Disease Treated with Radioactive Iodine
por: Young Oh, Seo, et al.
Publicado: (2017)

Graves' Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation
por: Hamid, Omnia A., et al.
Publicado: (2020)

Effect of liver dysfunction on outcome of radioactive iodine therapy for Graves’ disease
por: Ze, Yuyang, et al.
Publicado: (2022)

Association between radioactive iodine uptake and neutropenia in untreated Graves’ disease
por: Yang, Qian, et al.
Publicado: (2023)

Congenital Hypothyroidism Due To Maternal Radioactive Iodine Exposure During Pregnancy
por: Kurtoğlu, Selim, et al.
Publicado: (2012)

Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves' Disease
por: Park, Se Hee, et al.
Publicado: (2017)

Relative Adrenocortical Insufficiency Following Radioactive Iodine Therapy for Graves’ Disease: A Report of Two Cases
por: Zhao, Hanxin, et al.
Publicado: (2021)

A Case for Lithium Pretreatment Prior to Radioactive Iodine Ablation in Grave’s Disease
por: Thakkar, Aditi, et al.
Publicado: (2021)

FRI494 Ischemic Stroke After Radioactive Iodine Therapy In Graves Disease
por: Rave, Talia, et al.
Publicado: (2023)

Treatment of Graves’ Disease With a Combination of Low Iodine Diet and Potassium Iodide Plus Radioactive Iodine Treatment
por: Ebrahim, Ismail, et al.
Publicado: (2021)

Iatrogenic myxoedema madness following radioactive iodine ablation for Graves' disease, with a concurrent diagnosis of primary hyperaldosteronism
por: Larouche, V, et al.
Publicado: (2015)

SAT-427 Quality of Life Following Treatment for Graves’ Disease: A Comparison of Radioactive Iodine Ablation and Surgery
por: Rowe, Christopher W, et al.
Publicado: (2020)

Is Iodine Excess Associated with Increased Incidence of Hypothyroidism?
por: Kannan, Subramanian, et al.
Publicado: (2018)

MON-590 Outcomes Following Radioactive Iodine Therapy (RAI) in Hyperthyroid Patients with Grave’s Disease and Toxic Nodular Disease
por: Aljenaee, Khaled, et al.
Publicado: (2019)

De Novo Appearance of Pre-Tibial Myxedema After Radioactive Iodine Therapy for Graves’ Disease
por: Kuriakose, Cijoy K., et al.
Publicado: (2022)

Duration of antithyroid drug treatment may predict weight gain after radioactive iodine therapy in patients with Graves’ disease
por: Yotsapon, Thewjitcharoen, et al.
Publicado: (2022)

Hypothyroidism and its associated factors after radioactive iodine therapy among patients with hyperthyroidism in the Northeast Coast State of Malaysia
por: Wan Mohamed, Wan M.I., et al.
Publicado: (2018)

PSAT345 Neonatal Graves (NG) Affecting 3 Newborns of a Mother Treated with Radioactive Iodine (RAI) for Graves’ Disease (GD)
por: Ali, Dalal S, et al.
Publicado: (2022)

Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated (131)I dose
por: Wong, Ka Kit, et al.
Publicado: (2018)

Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves’ Disease: A Retrospective Cohort Study
por: Yamashita, Kaoru, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves’ Disease in Ethiopia
por: Mengistu, Habtamu Solomon, et al.
Publicado: (2022)

Dual attack: targeting the rare co-occurrence of myasthenia gravis and Graves’ disease with radioactive iodine therapy
por: Arcellana, Anna Elvira S, et al.
Publicado: (2021)

Radioactive Iodine-Induced Chronic Myeloid Leukemia in a Patient With Graves' Disease: A Case Report
por: Yasin, Ahmed K, et al.
Publicado: (2023)

Therapeutic applications of radioactive (131)iodine: Procedures and incidents with capsules
por: Al Aamri, Marwa, et al.
Publicado: (2016)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
por: Christina, Edelyn, et al.
Publicado: (2023)

Effect of radioactive iodine-induced hypothyroidism on longitudinal bone growth during puberty in immature female rats
por: Choi, Hyeonhae, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4la8ml8lmi4kmi38hn5u5voora